3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Multiple Myeloma
8
Pancreatic Neoplasms
7
Neoplasms
6
Neoplasms, Plasma Cell
4
Myelodysplastic Syndromes
4
Colorectal Neoplasms
3
Stomatitis
2
Skin Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Myeloproliferative Disorders
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Inflammation
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Myofibroma
1
Myelodysplastic-Myeloproliferative Diseases
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Motor Activity
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Limb-girdle muscular dystrophy, type 2C
1
Interventions
Exercise
4
Walking
2
Memantine
2
Donepezil
2
beta Carotene
1
Vitamin E
1
Ultraviolet Therapy
1
Time
1
Tai Ji
1
Surveys and Questionnaires
1
Sugars
1
Standard of Care
1
Sirolimus
1
Riluzole
1
Rehabilitation, Vocational
1
Referral and Consultation
1
Ramipril
1
Radiotherapy, Intensity-Modulated
1
Quality of Life
1
Population Groups
1
Pioglitazone
1
Palliative Care
1
Neuropsychological Tests
1
Mindfulness-Based Stress Reduction
1
Methods
1
Interviews as Topic
1
Ibuprofen
1
Hormones
1
Hematologic Tests
1
Geritol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cognitive Dysfunction
×
Ascorbic Acid
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled